In vivo expression of immunosuppressive cytokines in human papillomavirus-transfonned cervical cancer cells

Viral Immunology

Volumn 19, Issue 3, 2006, Pages 481-491

  Alcocer González, Juan Manuel ^a   Berumen, Jaime ^b   Taméz Guerra, Reyes ^a   Bermúdez Morales, Víctor ^c   Peralta Zaragoza, Oscar ^c   Hernández Pando, Rogelio ^d   Moreno, José ^e   Gariglio, Patricio ^f   Madrid Marina, Vicente ^c  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b UNISER School of Medicine   (Mexico)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^d National Institute of Medicine Sciences and Nutrition Salvador Subirán   (Mexico)

^e INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^f DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

CANCER CELL; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CELL TRANSFORMATION; CONDYLOMA; CONFERENCE PAPER; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; TH1 CELL; TH2 CELL; TH3 CELL; TUMOR ASSOCIATED LEUKOCYTE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; CYTOKINES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; PAPILLOMAVIRIDAE; T-LYMPHOCYTES, HELPER-INDUCER; TRANSFORMING GROWTH FACTOR BETA1; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 33750962552     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.481     Document Type: Conference Paper

References (54)

1. Aiba S, Rokugo M, and Tagami H: Immunohistologic analysis of the phenomenon of spontaneous regression of numerous flat warts. Cancer 1986;58:1246-1251.
2. Burdin N, Péronne C, Banchereau J, and Roussel F: Epstein-Barr virus induces B lymphocytes to produce human interleukin-10. J. Exp. Med. 1993;177:295-303.
3. Chen Q, Daniel V, Maher DW, and Hersey P: Production J of IL-10 by melanoma cells: Examination of its role in immunosuppression mediated by melanoma. Int. J. Cancer 1994;56:755-760.
4. Chomczynzki P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins form cell and tissue samples. Biotechniques 1993;15:532-536.
5. Clerici M, Merola M, Ferrario E, Trabattoni D, Villa ML, Stefanon B, Venzon DJ, Shearer GM, De Palo G, and Clerici E: Cytokine production patterns in cervical intraepithelial neoplasia: Association with papilloma-virus infection. J. Natl. Cancer Inst. 1997;89:245-250.
6. 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix. Cancer 1999;77:1107-1114.
7. Davies DH, McIndoe GAJ, and Chain BM: Cancer of the cervix: Prospects for immunological control. Int. J. Exp. Pathol. 1991;72:239-251.
8. de Gruijl TD, Bontkes HJ, van den Muysenberg AKC, van Oostveen JW, Stukart MJ, Verheijen RHM, van der Vange N, Snijders PJF, Meijer CJLM, Wallboomers JMM, and Scheper RJ: Differences in cytokine mRNA profiles between pre-malignant and malignant lesions of the uterine cervix. Eur. J. Cancer 1999;35:490-497.
9. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, and de Vries JE: Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 1991;174:1209-1220.
10. de Waal Malefyt R, Haanen J, Spits HM, Roncarolo MG, Te Velde A, Figdar C, Johnson K, Kastelein R, and de Vries JE: Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 1991;174:915-920.
11. Ding L, Linsley PS, Huang LY, Germain RN, and Shevach EM: IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 1993;151:1224-1234.
12. Edwards RP, Kuykendall K, Crowley-Nowick P, Partridge EE, Shingleton HM, and Mestrecky JT: Lymphocytes infiltrating in advanced grades of cervical neoplasia: CD8-positive cells are recruited to invasion. Cancer 1995;76:1411-1415.
13. Eustace D, Han X, Gooding R, Rowbotton A, Riches P, and Heyderman E: Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro. Gynecol. Oncol. 1993;50:15-19.
14. Evans CH, Flugelman AA, and DiPaolo JA: Cytokine modulation of immune defenses in cervical cancer. Oncology 1993;1993;50:245-251.
15. Fierlbeck G, Schiebel U, and Muller C: Immunohistology of genital warts in different stages of regression after therapy with interferon γ. Dermatologica 1989;179:191-195.
16. Florentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, and O'Garra A: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 1991;146:3444-3451.
17. Fiorentino DF, Zlotink A, Mossmann TR, Howard N, and O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991;147:3815-3822.
18. Frazer IH: Prevention of cervical cancer through papillomavirus vaccination. Nat. Rev. Immunol. 2004;4:46-54.
19. Gariglio P, Benitez-Bribiesca L, Berumen L, Alcocer-González JM, Tamez-Guerra R, and Madrid-Marina V: Therapeutic uterine-cervix cancer vaccines in humans. Arch. Med. Res. 1998;29:279-284.
20. Gastl TL, Liu F, Chen M, Albino AP, and Bander NH: Interleukin 10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer 1993;55:96-101.
21. Gentile G, Formelli G, Orsoni G, Rinaldi AM, and Busacchi P: Immunosuppression and human genital papillomavirus infection. Eur. J. Gynaecol. Oncol. 1991;12:79-81.
22. Giannini SL, Al-saleh W, Piron H, Jacobs N, Doyen J, Boniver J, and Delvenne P: Cytokine expression in squamous intraepithelial lesions of the uterine cervix: Implications for the generation of local immune suppression. Clin. Exp. Immunol. 1998;113:183-189.
23. Hedges SR, Agace WW, and Svanborg C: Epithelial cytokine responses and mucosal cytokine networks. Trends Microbiol. 1995;3:266-270.
24. Hilders CJ, Ras L, van Eendenburg JD, Nooyen Y, and Fleuren GJ: Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma. Int. J. Cancer 1994;57:805-813.
25. Kihana T, Tsuda H, Teshima S, Nomoto K, Tsugane S, Sonoda T, Matsuura S, and Hirohashi S: Prognostic significance of the over-expression of c-erbB-2 protein in adenocarcinoma of the uterine cervix. Cancer 1994;73:148-153.
26. Kobayashi A, Grenblatt RM, Anastos K, Minkoff H, Massad LS, Young M, Levine AM, Darragh TM, Weinberg V, and Smith-McCune KK: Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Res. 2004;64:6766-6774.
27. Kruger-Krasagakes S, Krasagakis K, Garbe C, Schmit E, Huls C, Balnkenstein T, and Diamantstein T: Expression of interleukin-10 in human melanona. Br. J. Cancer 1994;70:1182-1185.
28. Letterio JJ, and Roberts AB: Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 1998;16:137-161.
29. Melbye M, Palefsky J, Gonzales J, Ryder LP, Nielsen H, Bergmann O, Pinborg J, and Luger TA: Immune status as a determinant of human papillomavirus detection and its association with anal epithelial abnormalities. Int. J. Cancer 1990;46:203-206.
30. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, and Kishimoto T: IL-6 functions as an autocrine factor in renal cell carcinoma. FEBS Lett. 1989;250:607-610.
31. Mitchell MF, Hittelman WN, Hong WK, and Schottenfeld D: The natural history of cervical intraepithelial neoplasia: An argument for intermediate endpoint biomarkers. Cancer Epidemiol, Biomark. Prev. 1994;3:619-626.
32. Mitra AB, Murty VVVS, Pratap M, Sodhani P, and Chaganti RSK: erbB2 (HER/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix. Cancer Res. 1994;54:637-639.
33. Moore K, Vieira P, Fiorentino D, Trounstine ML, Khan TA, and Mosmann T: Homology of cytokine synthesis inhibitory factor (IL-10) to Epstein-Barr virus gene BCRF1. Science 1990;248:1230-1234.
34. Mosmann TR, and Sad S: The expanding universe of T-cells subsets: Th1, Th2 and more. Immunol. Today 1997;17:138-146.
35. Nitta T, Hishii M, Sato K, and Okumura K: Selective expression of interleukin-10 gene within glioblastoma multiforme. Brain Res. 1994;649:122-128.
36. Ocadiz R, Sauceda R, Cruz M, Greaf A, and Gariglio P: High correlation between molecular alterations of the c-myc oncogene and uterine-cervix carcinoma. Cancer Res. 1987;47:4173-4177.
37. 1 promoter throughout Sp1 recognition sequence. Viral Immunol. 2006;19:468-480.
38. Pinion SB, Kennedy JH, Miller LM, and McLean AB: Oncogene expression in cervical intraepitelial neoplasia and invasive cancer of cervix. Lancet 1991;337:819-820.
39. Rivas J, and Ullrich SE: Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes: Essential role for keratinocytes-derived-IL-10. J. Immunol. 1992;149:3865-3871.
40. Sagae S, Kuzumaki N, Hizada T, Mugikura Y, Kudo R, and Hashimoto M: Oncogene expression and prognosis of invasive squamous cell carcinomas of the uterine cervix. Cancer 1989;63:1577-1582.
41. Sheu BC, Lin RH, Lien HC, Ho HN, Hsu SM, and Huang SC: Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J. Immunol. 2001;167:2972-2978.
42. Shimth DR, Kunkel SL, Burdick MD, Wilke CA, Orringer MB, Whyte RI, and Stricter RM: Production of interleukin 10 by human bronchogenic carcinoma. Am. J. Pathol. 1994;145:18-25.
43. Smith TR, and Larche M: Investigating T cell activation and tolerance in vivo: Peptide challenge in allergic asthmatics. Cytokine 2004;28:49-54.
44. Stanley M: Immune responses to human papillomavirus. Vaccine 2006;24(Suppl. 1):S16-S22.
45. Taga K, and Tosato G: IL-10 inhibits human T-cell proliferation and IL-2 production. J. Immunol. 1992;148:1143-1148.
46. + T cells in cancer immunotherapy. Curr. Opin. Immunol. 1994;6:741-745.
47. Tsukui T, Hildesheim A, Schiffman M, Lucci J III, Contois D, Lawler P, Rush B, Lorincz A, Corrigan A, Burk R, Qu W, Clerici M, Shearer M, Carbone G, Scott D, Houghten D, and Berzofsky JA: Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: Correlation with cervical pathology. Cancer Res. 1996;56:3967-3974.
48. Valdespino V, Gorodezky C, Ortiz V, Kaufmann AM, Roman-Basaure E, Vazquez A, and Berumen J: HFV16-specific cytotoxic T lymphocyte responses are detected in all HPV16-positive cervical cancer patients. Gynecol. Oncol. 2005;96:92-102.
49. Vieira P, de Waal Malefy T, Dang R, Johnson MN, Kaseleim KE, Florentine R, de Vries DF, Roncarolo JE, Mosmann TR, and Moore KW: Isolation and expression of human cytokine synthesis inhibitory factor (CSIF-IL-10) cDNA clones: Homology to Epstein-Barr virus open reading frame BCRF1. Proc. Natl. Acad. Sci. U.S.A. 1991;88:1172-1176.
50. Walboomers JMM, Jacobs MV, Manos M, Bosch X, Kummer A, Shah KV, Snijders PJF, Peto J, Meijer CJLM, and Muñoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999;189:12-19.
51. Wang P, Wu P, Siegal MI, Egan RW, and Billah MM: IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 1994;153:811-816.
52. Welters MJ, de Jong A, van den Eeden SJ, van der Hulst JM, Kwappenberg KM, Hassane S, Franken KL, Drijfhout JW, Fleuren GJ, Kenter G, Melief CJ, Offringa R, and van der Burg SH: Frequent display of human papillomavirus type 16 E6-specific memory T-helper cells in the healthy population as witness of previous viral encounter. Cancer Res. 2003;63:636-641.
53. Yamamura M, Modlin RL, Ohmen JD, and Moy RL: Local expression of anti-inflammatory cytokines in cancer. J. Clin. Invest. 1993;91:1005-1010.
54. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshinkura H, and Iwamoto A: Detection and typing of multiple genital human papilloma-viruses by DNA amplification with consensus primers. Jpn. J. Cancer Res. 1991;82:524-531.